Atlas Trials

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Clinical trial NCT00775073 · COMPLETED

Trial details

NCT number
NCT00775073
Sponsor
Gerhard Treiber
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2008-10-01
Primary completion
2011-01-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.